AstraZeneca Operating Expenses 1992-2025 | AZN
AstraZeneca annual/quarterly operating expenses history and growth rate from 1992 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- AstraZeneca operating expenses for the quarter ending June 30, 2025 were $10.949B, a 7.43% increase year-over-year.
- AstraZeneca operating expenses for the twelve months ending June 30, 2025 were $45.177B, a 12.71% increase year-over-year.
- AstraZeneca annual operating expenses for 2024 were $44.07B, a 17.15% increase from 2023.
- AstraZeneca annual operating expenses for 2023 were $37.618B, a 7.33% decline from 2022.
- AstraZeneca annual operating expenses for 2022 were $40.594B, a 11.64% increase from 2021.
| AstraZeneca Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $44,070 |
| 2023 | $37,618 |
| 2022 | $40,594 |
| 2021 | $36,361 |
| 2020 | $21,455 |
| 2019 | $21,460 |
| 2018 | $18,703 |
| 2017 | $18,788 |
| 2016 | $18,100 |
| 2015 | $20,594 |
| 2014 | $24,410 |
| 2013 | $22,094 |
| 2012 | $19,825 |
| 2011 | $20,796 |
| 2010 | $21,775 |
| 2009 | $21,261 |
| 2008 | $5,179 |
| 2007 | $22,193 |
| 2006 | $19,344 |
| 2005 | $17,641 |
| 2004 | $16,656 |
| 2003 | $14,938 |
| 2002 | $14,078 |
| 2001 | $13,398 |
| 2000 | $15,077 |
| 1999 | $15,888 |
| 1998 | $7,509 |
| 1997 | $6,869 |
| 1996 | |